Documenting pessary offer prior to hysterectomy for management of pelvic organ prolapse.

Int Urogynecol J

Department of Obstetrics and Gynecology, Michigan Medicine, 1500 E. Medical Center Dr, Ann Arbor, MI, 48109, USA.

Published: May 2019

Objectives: To (1) determine the proportion of hysterectomy cases with documentation of pessary counseling prior to prolapse surgery and (2) identify variables associated with women offered a pessary.

Study Design: The Michigan Surgical Quality Collaborative (MSQC) is a hysterectomy improvement initiative. Hysterectomies from 2013 to 2015 in which prolapse was the principal diagnosis were included. "Pessary offer" was defined as documentation showing the patient declined, could not tolerate, or failed a pessary trial. Bivariate analyses were used to compare demographics, medical history, surgical route, concomitant procedures (colpopexy or colporrhaphy), and intra- and postoperative complications between women with and without pessary offer. Hierarchical logistic regression was used to determine factors independently associated with pessary offer. Risk-adjusted pessary offer rates by hospital were calculated.

Results: The adjusted rate of pessary offer was 25.2%, ranging from 3 to 76% per hospital. Bivariate comparisons showed differences between women with and without pessary offer in age, tobacco use, prior pelvic surgery, insurance status, surgical approach, secondary indication for surgery, concomitant prolapse procedure, teaching hospital status and hospital bed size. In logistic regression, odds of pessary offer increased with age > 55 years (OR 1.45, 95% CI 1.12-1.88, p = 0.006), Medicare insurance (OR 1.65, 95% CI 1.30-2.10, p < 0.0001), and a concomitant procedure (OR 1.5, 95% CI 1.16-1.93, p = 0.002). Postoperative urinary tract infections were more common in patients offered a pessary (6.4% vs. 2.5%, p < 0.0001), but other complications were similar.

Conclusions: Overall, only one-quarter of hysterectomies for prolapse in MSQC hospitals had documentation of pessary counseling-suggesting an opportunity to improve documentation, counseling regarding pessary use, or both.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6470058PMC
http://dx.doi.org/10.1007/s00192-018-3696-1DOI Listing

Publication Analysis

Top Keywords

pessary offer
28
pessary
8
women pessary
8
logistic regression
8
offer
7
documenting pessary
4
offer prior
4
prior hysterectomy
4
hysterectomy management
4
management pelvic
4

Similar Publications

Pessary Placement for Voiding Dysfunction Due to Prolapse Among Neurologically Intact Women.

Urogynecology (Phila)

January 2025

Division of Female Pelvic Medicine and Reconstructive Surgery, Northwestern Medicine, Chicago, IL.

Importance: Literature surrounding conservative management of voiding dysfunction (VD) due to pelvic organ prolapse (POP) is limited.

Objective: The objective of this study was to evaluate the effect of pessaries on VD in women with symptomatic POP.

Study Design: This was a retrospective case series of adult women who underwent a pessary fitting for POP and VD between January 2010 to December 2022 at 2 tertiary care centers.

View Article and Find Full Text PDF

Use of vaginal pessary in women with symptomatic pelvic organ prolapse: Risk factors for failure one year after insertion.

Eur J Obstet Gynecol Reprod Biol

December 2024

Department of Obstetrics and Gynaecology, Caen University Hospital, Caen, France; Inserm U1086 "ANTICIPE", Unité de Recherche Interdisciplinaire pour la Prévention et le Traitement des Cancers, Caen, France.

Introduction: Vaginal pessaries are offered as a first-line treatment for symptoms associated with pelvic organ prolapse (POP). The objective of our study was to identify risk factors for failure of pessary use within 1 year of insertion.

Materials And Methods: We prospectively included women who accepted a pessary fitting for symptomatic POP.

View Article and Find Full Text PDF
Article Synopsis
  • - The study investigates the impact of the Restifem® pessary on pelvic floor function in postpartum women, evaluating its effectiveness as both a preventive and therapeutic device from 6 weeks to 12 months after delivery.
  • - 857 women participated, with 137 using the pessary and 133 not; findings revealed that pessary users experienced significantly worse pelvic floor function initially but showed greater improvement in scores related to bladder and pelvic organ prolapse over time.
  • - The results suggest that using the pessary contributes to improved recovery of pelvic floor function, particularly for women experiencing higher levels of dysfunction postpartum, while also highlighting the study's legitimacy through registration in a clinical trials database.
View Article and Find Full Text PDF
Article Synopsis
  • * The study developed immediate-release film and pessary formulations containing TDF and ZAD, which showed effective drug release within 1-90 minutes and were tested for their safety and antiviral effectiveness in the lab.
  • * Results indicated that while ZAD had moderate antiviral activity, TDF was very effective, and their combination produced synergistic effects, suggesting these formulations could enhance treatment for HSV-2 with fewer systemic side effects, though further studies are needed before clinical use.
View Article and Find Full Text PDF

Pelvic organ prolapse (POP) affects many women and is often managed with pessary treatment, yet predicting the success of fitting remains challenging. This study aims to identify anatomical parameters associated with successful and unsuccessful pessary treatment using dynamic magnetic resonance imaging (dMRI). A cross-sectional study in Maastricht University Medical Centre (MUMC+), the Netherlands.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!